Theodore N. Keltz
Dr. Keltz is interested in the full breadth of clinical cardiology in adolescents and adults, from risk factor assessment and treatment, to the care of symptoms and diseases. He brings a special expertise in the integration of bedside care with noninvasive imaging.
<p>Dr. Keltz received his BS with honors in Biology, magna cum laude, and his MD in the accelerated 6 year Biomedical Program at Rensselaer Polytechnic Institute and Albany Medical College of Union University. He was inducted into Alpha Omega Alpha, the medical school honor society, in the autumn of his junior year in medical school.</p><p>Dr. Keltz did an internship and residency in Internal Medicine at Mt Sinai Hospital and a fellowship in Cardiovascular Disease at Montefiore Medical Center. He then joined the late Drs. Julian Frieden, Jerome Cooper, and. Bernard Gitler in cardiology practice in New Rochelle. The practice became Westchester Heart Specialists and included Dr. Michael Johnson and Dr. Donald Miller. He cared for patients at New Rochelle Hospital, Montefiore Medical Center, and Columbia University Medical Center. In 2012 Westchester Heart Specialists became a part of Montefiore Medical Center.</p><p>Dr. Keltz was awarded the the Elmer Schacht Award for Microbiology in medical school and the Montefiore Medical Center House Staff Award for Excellence in Teaching and Patient Care in 1987.</p><p>Dr. Keltz is Board Certified in Internal Medicine, Cardiovascular Disease, Nuclear Cardiology, and Adult Echocardiography.</p><p>Dr. Keltz served on the Board of Directors, American Heart Association, Westchester-Putnam Region from 1995-2007 and as president from 2000-2006.</p><p>Dr. Keltz is currently the President of the Medical Board of Montefiore New Rochelle Hospital.</p>
Nils A. Guttenplan
<p>Dr. Guttenplan is committed to improving the patient's quality of life and prognosis across the spectrum of heart rhythm disorders. All contemporary approaches including pacemakers, defibrillators, catheter ablations, and left atrial appendage occlusion devices are drawn upon to achieve this aim.</p>
<p>Dr. Guttenplan is the principle investigator at Montefiore in an outcomes study of a left ventricular quadrapolar pacing lead. During the study he as adapted the use of an interventional snare technique. This approach has allowed for successful left ventricular lead placement, that would not have been possible with the conventional approach. Dr. Guttenplan is also a co-investigator in the division's ablation studies.</p>
<p>Nils A. Guttenplan, MD, is an Attending Physician in the Cardiology Department at Montefiore. His clinical focus is improving the patient's quality of life and prognosis across the spectrum of heart rhythm disorders. He has an interest in all contemporary approaches to achieve this aim, including pacemakers, defibrillators, catheter ablations, and left atrial appendage occlusion devices. Dr. Guttenplan joined the Montefiore team in 2018.</p><p>Dr. Guttenplan attended New York Medical College where he received his Doctor of Medicine. In 2004, Dr. Guttenplan completed a residency in Internal Medicine at St. Vincent?s Medical Center. He completed a fellowship in Cardiovascular Disease at our Albert Einstein College of Medicine, followed by a fellowship in Clinical Cardiac Electrophysiology at New York University.</p><p>Dr. Guttenplan is the Principal Investigator in a study on left ventricular quadripolar pacing lead. During the study, he has developed the use of an interventional snare technique that has allowed for successful left ventricular lead placement that would not have been possible with the conventional approach. Dr. Guttenplan is also a co-Investigator in the division's ablation studies. His work has been published in numerous peer-reviewed journals.</p>
Jay N. Gross
<p>Dr. Gross specializes in complex electrophysiology (EP) management problems as well as issues related to implantation and management of all types of implantable electrical devices, with a focus on lead extraction.</p>
<p>Dr. Gross has been a principal site or co-investigator in many of the critical clinical trials that have established the utility and indications for pacemaker mode selection, rate modulated pacing, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy. Most recently, he has been involved in studies designed to define the role of temporary external defibrillator systems and the safety of implantable devices in the magnetic resonance imaging (MRI) setting. He has also been principal or co-author of dozens of scientific publications.</p>
<p>Jay N. Gross, MD, serves as an Attending Physician and Director of the Implantable Electrical Devices Service at Montefiore, as well as Professor of Medicine (Cardiology) at our <a href="http://www.einstein.yu.edu/faculty/2274/jay-gross/" rel="noopener noreferrer" target="_blank">Albert Einstein College of Medicine</a>. His clinical focus is on complex electrophysiology (EP) management problems as well as issues related to implantation and management of all types of implantable electrical devices, with a focus on lead extraction.</p><p>After graduating from our Albert Einstein College of Medicine, and completing his residency at Montefiore in Internal Medicine, Dr. Gross continued on to complete a cardiology fellowship at Montefiore. <br /><br />Dr. Gross has been a principal site or co-investigator in many of the critical clinical trials that have established the utility and indications for pacemaker mode selection, rate-modulated pacing, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy. Most recently, he has been involved in studies designed to define the role of temporary external defibrillator systems and the safety of implantable devices in the magnetic resonance imaging (MRI) setting. He has also been principal or co-author of dozens of scientific publications.</p><p>Recent clinical highlights for Dr. Gross include: the first reported cases of implantation of subcutaneous ICDs in heart transplant patients, simultaneous lead extraction and debulking of large vegetations in patients with endocarditis, concomitant lead extraction and implantation of leadless pacemakers, and care for of congenital heart patients who require both transvenously implanted devices and subcutaneous ICDs.</p><p>Dr. Gross is board certified in Internal Medicine, Cardiology, and Cardiovascular Electrophysiology as well as a Certified Cardiac Device Specialist (CCDS) by the International Board of Heart Rhythm Examiners. He is a Fellow of the American College of Cardiology and a member of the Heart Rhythm Society. Dr. Gross has served on the Writing Committee of the International Board of Heart Rhythm Board of Examiners for over two decades and now serves on its board of directors. He has been named to the Castle Connolly/NY Magazine List of Best EP Doctors in New York for the past two years.</p>
Mark A. Greenberg
Marco Gentilucci
Cardiology
Past research has focused on congestive heart failure.
Kevin J. Ferrick
<p>Cardiac arrhythmia management, cardiovascular risk stratification, ventricular tachycardia, atrial fibrillation, ablation of cardiac arrhythmias, as well as pacemaker and ICD therapy.</p>
<p>Noninvasive cardiovascular risk stratification, management of supraventricular and ventricular arrhythmias, ICD therapy and the management of cardiovascular risk, as well as demographic risk factors for atrial fibrillation.</p>
<p>Kevin J. Ferrick, MD, is an Attending Physician, Director of the Holter/ECG Department, Director of the Cardiology Training Program, and Professor of Medicine (Cardiology) at Montefiore and our <a href="http://www.einstein.yu.edu/faculty/2739/kevin-ferrick/" rel="noopener noreferrer" target="_blank">Albert Einstein College of Medicine</a>. His clinical focus is on cardiac arrhythmia management, cardiovascular risk stratification, ventricular tachycardia, atrial fibrillation, pacemaker and implantable cardioverter defibrillator (ICD) therapy, and ablation of cardiac arrhythmias. Dr. Ferrick joined the Montefiore team in 1992.</p><p>Dr. Ferrick received his Bachelor of Chemical Engineering in 1973 from the Cooper Union in New York. In 1977, he received his Doctor of Medicine from the Medical College of Wisconsin. Dr. Ferrick completed an internship and residency in medicine at Montefiore from 1977 to 1980. He then completed fellowships in Clinical Cardiology and Clinical Electrophysiology at Columbia-Presbyterian Medical Center in New York from 1980 to 1983.</p><p>Dr. Ferrick’s research focuses on noninvasive cardiovascular risk stratification, management of supraventricular and ventricular arrhythmias, ICD therapy and the management of cardiovascular risk, and demographic risk factors for atrial fibrillation. His research on these topics has been published in over 100 reviewed journals, abstracts, books, and articles. He has been an invited speaker to numerous national presentations, courses, lectures, and seminars.</p><p>In 2009, Dr. Ferrick was named one of the Best Doctors by<em>New York</em>magazine<em></em>and is currently still one of Castle Connolly’s Top Doctors. He is board certified by the American Board of Internal Medicine and a member of numerous professional societies, including the American College of Cardiology and the American Heart Association. Healso has board certification in Cardiovascular Disease and Clinical Cardiac Electrophysiology.</p>
Jonathan A. Bradlow
Dr. Jonathan A. Bradlow specializes in all areas of noninvasive cardiology, with a focus on medical treatment of hypertension, lipids, heart failure, arrhythmias and coronary artery disease both for primary and secondary prevention of disease and optimization of outcomes.
Anna E. Bortnick
<p>Dr. Anna Bortnick earned her medical degree and doctorate in Cardiovascular Biology from Drexel University in Philadelphia and a master's degree in clinical research methods from Yeshiva University through the Clinical Research Training Program at Albert Einstein College of Medicine. She completed internship and residency in internal medicine at Brigham and Women's Hospital in Boston. She joined the Division of Cardiology from the Hospital of the University of Pennsylvania, where she completed fellowships in both interventional and general cardiology with a focus in structural heart disease, including transcatheter aortic valve replacement. Dr. Bortnick's research has been funded by grants from the American Heart Association, Empire Clinical Research Investigator Program and the Albert Einstein Institute for Clinical and Translational Research. Her research is centered on cardiac aging, including biomarkers and genetics of cardiac calcification. She co-founded the Maternal Fetal Medicine-Cardiology Joint Program at Montefiore, which has gained national recognition for treatment of high risk cardiac disease in pregnancy, and served as a member of the Einstein IRB and Course Director for Cardiology Grand Rounds. She is the Program Director for the Interventional Cardiology Fellowship Program. Dr. Bortnick is ABIM Board Certified in Interventional Cardiology and Cardiovascular Medicine and draws upon her expertise in invasive procedures to provide patients with comprehensive care of cardiac disease. </p>
Cardiac catheterization, hemodynamics, percutaneous coronary intervention (PCI), transcatheter aortic valve replacement (TAVR), aortic and mitral balloon valvuloplasty, atrial septal defect and patent foramen ovale closure, intracardiac echocardiography, alcohol septal ablation, pericardiocentesis, endomyocardial biopsy of native and transplanted hearts, paravalvular leak closure, pulmonary vein stenosis, left ventricular pseudoaneurysm closure
index of microvascular resistance in microvascular dysfunction, biomarkers and genetics of calcific aortic stenosis, quality issues in TAVR, intravenous infusion of biologics for the treatment of atherosclerosis
<p><a href="https://www.ncbi.nlm.nih.gov/pubmed/31048102">Biomarkers of mineral metabolism and progression of aortic valve and mitral annular calcification: The Multi-Ethnic Study of Atherosclerosis.</a></p>
<div class="supp">
<p class="desc">Bortnick AE, Xu S, Kim RS, Kestenbaum B, Ix JH, Jenny NS, de Boer IH, Michos ED, Thanassoulis G, Siscovick DS, Budoff MJ, Kizer JR.</p>
<p class="details"><span class="jrnl" title="Atherosclerosis">Atherosclerosis</span>. 2019 Jun;285:79-86. doi: 10.1016/j.atherosclerosis.2019.04.215. Epub 2019 Apr 13.</p>
</div>
<div class="aux">
<div class="resc"><dl class="rprtid"><dt>PMID:31048102</dt><dt></dt></dl></div>
</div>
<p class="title"><a href="https://www.ncbi.nlm.nih.gov/pubmed/30278179">Addressing maternal mortality: the pregnant cardiac patient.</a></p>
<div class="supp">
<p class="desc">Wolfe DS, Hameed AB, Taub CC, Zaidi AN, Bortnick AE.</p>
<p class="details"><span class="jrnl" title="American journal of obstetrics and gynecology">Am J Obstet Gynecol</span>. 2019 Feb;220(2):167.e1-167.e8. doi: 10.1016/j.ajog.2018.09.035. Epub 2018 Sep 29.</p>
</div>
<div class="aux">
<div class="resc"><dl class="rprtid"><dt>PMID:30278179</dt><dt></dt><dt></dt><dt></dt></dl>
<p class="title"><a href="https://www.ncbi.nlm.nih.gov/pubmed/27411840">Association of inflammatory, lipid and mineral markers with cardiac calcification in older adults.</a></p>
<div class="supp">
<p class="desc">Bortnick AE, Bartz TM, Ix JH, Chonchol M, Reiner A, Cushman M, Owens D, Barasch E, Siscovick DS, Gottdiener JS, Kizer JR.</p>
<p class="details"><span class="jrnl" title="Heart (British Cardiac Society)">Heart</span>. 2016 Nov 15;102(22):1826-1834. doi: 10.1136/heartjnl-2016-309404. Epub 2016 Jul 13.</p>
</div>
<div class="aux">
<div class="resc"><dl class="rprtid"><dt>PMID:27411840</dt> </dl></div>
</div>
<dl class="rprtid"><dt></dt></dl></div>
</div>
<p>Anna E. Bortnick, MD, is Associate Director, Structural and Valvular Heart Disease, Program Director, Interventional Cardiology Fellowship and Co-Founder and <br />Co-Director, Maternal Fetal Medicine-Cardiology Joint Program at Montefiore. She is also Assistant Professor of Medicine at our Albert Einstein College of Medicine. Dr. Bortnick specializes in interventional procedures for high risk patients.</p><p>In 1997, Dr. Bortnick received her Bachelor of Science in biochemistry and molecular biology at Chestnut Hill College. She then attended Drexel University College of Medicine from 1997 to 2005, where she received her Doctor of Medicine and Doctor of Philosophy. In 2005, she received the Rubin Award from Drexel University for academic and clinical medicine. Following this, Dr. Bortnick received her Master in Clinical Research at Albert Einstein College of Medicine in 2018. She began her postgraduate training in 2005 with a year-long internship in internal medicine at Brigham and Women’s Hospital. In 2008, she completed a residency in internal medicine at the same institute. From 2008 to 2012, Dr. Bortnick trained at the Hospital of the University of Pennsylvania, completing fellowships in general cardiology and interventional cardiology. Upon completion, she continued her training in 2015 at Montefiore and Albert Einstein College of Medicine with a fellowship in the Empire Clinical Research Investigator Program.</p><p>Her research focuses on cardiac aging, including biomarkers and genetics of cardiac calcification. Dr. Bortnick’s work has been published in numerous peer-reviewed journals, articles, books and she has presented her work nationally.</p><p>Dr. Bortnick is board certified by the American Board of Internal Medicine and is a member of the American Heart Association and the American College of Cardiology. </p>